“Reinventing GPC, a Global GPC”
Time：
2026-08-21 08:48
Author：
xieyijun
In Minhang, See the Next Generation of Biopharma
Time：
2026-08-20 08:48
Author：
xieyijun
Pfizer's CEO, Going All In with Frenzied Betting
A Sexagenarian CEO in His Prime
Time：
2026-08-19 08:17
Author：
xieyijun
U.S. Industry Heatedly Debates: Should Chinese Biotechnology Be Contained?
Divisions and Anxieties Within U.S. Industry
Time：
2026-08-18 08:25
Author：
xieyijun
CPIC 2026 | The Birth of the First Global Conference on New Drugs from Major Countries
"With a century of history, CPIC stands unrivaled."
Time：
2026-08-17 08:36
Author：
xieyijun
Freehand brushwork blue ocean new journey -- CPIC, big country new drugs to a higher level
Stand at the forefront, always stand at the forefront
Time：
2026-08-17 08:30
Author：
xieyijun
Multinational pharmaceutical companies enter the AI battlefield
The increasingly intense hand to hand combat
Time：
2026-08-12 09:05
Author：
写意君
Recommended content
mRNA tumor vaccine "seller", entering a golden age
When a Biotech company that has been acquired achieves rare growth
AI、 Cold bench and puzzle, when will 'one person, one seedling' come to an end?
This road is long, but the threshold has already been crossed.
The "economic accounts" of immunology business development are being rewritten
After rejecting a $30 billion acquisition offer, a biotech company has emerged as a giant
determination for independence
联系我们
同写意
写意宣发
同写意Biotech
同写意微服务